Analysis of Real-World Dosing Patterns for the 3 FDA-Approved Medications in the Treatment of Fibromyalgia.
Saved in:
| Title: | Analysis of Real-World Dosing Patterns for the 3 FDA-Approved Medications in the Treatment of Fibromyalgia. |
|---|---|
| Authors: | White C; Engagement Manager, IQVIA, New York, NY., Kwong WJ; Executive Director, HEOR, Daiichi Sankyo, Basking Ridge, NJ., Armstrong H; Scientific Advisor, IQVIA., Behling M; Research Associate, IQVIA., Niemira J; Senior Statistician, IQVIA., Lang K; Principal, IQVIA, during the study. |
| Source: | American health & drug benefits [Am Health Drug Benefits] 2018 Sep; Vol. 11 (6), pp. 293-301. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Amplity Medical Communications Country of Publication: United States NLM ID: 101479877 Publication Model: Print Cited Medium: Print ISSN: 1942-2962 (Print) Linking ISSN: 19422962 NLM ISO Abbreviation: Am Health Drug Benefits Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30464796 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Analysis of Real-World Dosing Patterns for the 3 FDA-Approved Medications in the Treatment of Fibromyalgia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22White+C%22">White C</searchLink>; Engagement Manager, IQVIA, New York, NY.<br /><searchLink fieldCode="AU" term="%22Kwong+WJ%22">Kwong WJ</searchLink>; Executive Director, HEOR, Daiichi Sankyo, Basking Ridge, NJ.<br /><searchLink fieldCode="AU" term="%22Armstrong+H%22">Armstrong H</searchLink>; Scientific Advisor, IQVIA.<br /><searchLink fieldCode="AU" term="%22Behling+M%22">Behling M</searchLink>; Research Associate, IQVIA.<br /><searchLink fieldCode="AU" term="%22Niemira+J%22">Niemira J</searchLink>; Senior Statistician, IQVIA.<br /><searchLink fieldCode="AU" term="%22Lang+K%22">Lang K</searchLink>; Principal, IQVIA, during the study. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101479877%22">American health & drug benefits</searchLink> [Am Health Drug Benefits] 2018 Sep; Vol. 11 (6), pp. 293-301. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Amplity+Medical+Communications%22">Amplity Medical Communications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101479877 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>1942-2962 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219422962%22">19422962 </searchLink><i>NLM ISO Abbreviation: </i>Am Health Drug Benefits <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30464796 |
| RecordInfo | BibRecord: BibEntity: Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 293 Titles: – TitleFull: Analysis of Real-World Dosing Patterns for the 3 FDA-Approved Medications in the Treatment of Fibromyalgia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: White C – PersonEntity: Name: NameFull: Kwong WJ – PersonEntity: Name: NameFull: Armstrong H – PersonEntity: Name: NameFull: Behling M – PersonEntity: Name: NameFull: Niemira J – PersonEntity: Name: NameFull: Lang K IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2018 Sep Type: published Y: 2018 Identifiers: – Type: issn-print Value: 1942-2962 Numbering: – Type: volume Value: 11 – Type: issue Value: 6 Titles: – TitleFull: American health & drug benefits Type: main |
| ResultId | 1 |
